BFTI completes initial financing.SCOTTSDALE, Ariz.--(BUSINESS WIRE)--July 8, 1996--Bio Fluorescent Technologies Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:BFTI) (BFTI) Monday announced that it has completed a $550,000 convertible debenture in its initial round of financing. A more in-depth announcement will be forthcoming. Bio Fluorescent Technologies Inc. is an international marketing company specializing in leading edge human screening and confirmatory immuno assays including HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. . The company's flagship product known as the MEHICA GP120 combines leading edge satellite imaging technology with state-of-the-art biochemistry. The MEHICA GP120 provides the only mechanized mech·a·nize tr.v. mech·a·nized, mech·a·niz·ing, mech·a·niz·es 1. To equip with machinery: mechanize a factory. 2. equipment available today to quickly and accurately process immuno-fluorescent assay (IFA Immunofluorescent assay (IFA) A blood test sometimes used to confirm ELISA results instead of using the Western blotting. In an IFA test, HIV antigen is mixed with a fluorescent compound and then with a sample of the patient's blood. ) tests. CONTACT: Bio Fluorescent Technologies Inc., Scottsdale George, 800/870-1233 Website Address: http://www.biofluor.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion